Product
LYG-LIV0001
1 clinical trial
1 indication
Indication
End-Stage Liver DiseaseClinical trial
A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver DiseaseStatus: Recruiting, Estimated PCD: 2026-02-22